Consolidated Segment Information by Division

Download

January 1 to December 31

€ million

Silicones

Polymers

Biosolutions

Polysilicon

Other

Consolidation

Group

2024

External sales

2,805.2

1,448.5

374.9

949.2

144.0

–

5,721.8

Internal sales

0.1

14.8

–

-14.9

–

Total sales

2,805.3

1,463.3

374.9

949.2

144.0

-14.9

5,721.8

EBIT

203.3

136.0

-17.1

70.0

-101.4

-0.7

290.1

Depreciation/amortization

143.9

58.4

52.2

123.4

94.8

–

472.7

EBITDA

347.2

194.4

35.1

193.4

-6.6

-0.7

762.8

EBIT includes: result from investments in joint ventures and associates

6.3

–

12.8

–

19.1

Impairment of fixed assets

0.8

–

9.2

–

10.0

Asset additions¹

266.3

75.4

49.3

199.7

75.3

–

666.0

Additions to financial assets

–

0.5

–

0.5

Asset additions

266.3

75.4

49.3

199.7

75.8

–

666.5

Assets (Dec. 31)

2,698.6

941.7

759.7

1,259.8

3,750.5

-0.4

9,409.9

Liabilities (Dec. 31)

1,200.8

426.1

234.4

778.8

1,932.8

–

4,572.9

Net assets (Dec. 31)

1,497.8

515.6

525.3

481.0

1,817.7

-0.4

4,837.0

Investments in joint ventures and associates included in net assets (Dec. 31)²

92.7

–

883.5

–

976.2

Research and development expenses

77.2

34.3

9.6

40.8

41.8

–

203.7

Employees (Dec. 31)

6,242

1,613

1,189

2,375

5,218

–

16,637

Employees (average)

6,167

1,607

1,187

2,352

5,207

–

16,520

2023

External sales

2,741.3

1,562.0

337.2

1,599.3

162.4

–

6,402.2

Internal sales

0.1

17.8

–

-17.9

–

Total sales

2,741.4

1,579.8

337.2

1,599.3

162.4

-17.9

6,402.2

EBIT

101.6

203.0

-20.1

203.3

-82.4

-0.5

404.9

Depreciation/amortization

134.8

50.1

26.6

117.3

89.9

–

418.7

EBITDA

236.4

253.1

6.5

320.6

7.5

-0.5

823.6

EBIT includes: result from investments in joint ventures and associates

3.9

–

45.4

–

49.3

Impairment of fixed assets

–

Asset additions¹

241.4

74.1

155.5

165.1

73.5

–

709.6

Additions to financial assets

–

0.6

–

0.6

Asset additions

241.4

74.1

155.5

165.1

74.1

–

710.2

Assets (Dec. 31)

2,499.6

948.1

762.6

981.3

3,662.9

-0.1

8,854.4

Liabilities (Dec. 31)

1,079.4

402.6

239.1

761.6

1,791.9

-0.1

4,274.5

Net assets (Dec. 31)

1,420.2

545.5

523.5

219.7

1,871.0

–

4,579.9

Investments in joint ventures and associates included in net assets (Dec. 31)

97.8

–

857.4

–

955.2

Research and development expenses

72.3

34.3

5.5

33.5

38.5

–

184.1

Employees (Dec. 31)

6,040

1,622

1,191

2,322

5,203

–

16,378

Employees (average)

6,087

1,612

1,109

2,298

5,145

–

16,251

¹	Intangible assets; property, plant and equipment; investment property; excluding right-of-use assets.
²	Includes assets held for sale.
The segment information by region is an integral part of the Notes to the consolidated financial statements. For explanations of the key indicators, see Note 22.

Annual Report 2024

Consolidated Segment Information by Division

Related Links

We Challenge the Status Quo.